Rice G. William's most recent trade in Aptose Biosciences Inc was a trade of 100,000 Common Shares done at an average price of $0.2 . Disclosure was reported to the exchange on Nov. 25, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc | William G. Rice | Director, Chair, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 25 Nov 2024 | 100,000 | 613,252 (0%) | 0% | 0.2 | 20,000 | Common Shares |
| Aptose Biosciences Inc | William G. Rice | Director, Chair, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Nov 2024 | 50,000 | 50,000 | - | - | Warrants | |
| Aptose Biosciences Inc | Rice G. William | Director, Chair, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) |